Background. Immune activation in patients with chronic heart failure may be
secondary to endotoxin (lipopolysaccharide) action. We investigated the hy
pothesis that altered gut permeability with bacterial translocation and end
otoxaemia would be increased in patients with oedema secondary to congestiv
e heart failure.
Methods. We compared 20 patients who had chronic heart failure with recent-
onset peripheral oedema (mean age 64 years [SD 10], New York Heart Associat
ion [NYHA] class 3.3 [0.7]), 20 stable non-oedematous patients with chronic
heart failure (mean age 63 years [19], NYHA class 2.6 [0.7]), and 14 healt
hy volunteers (mean age 55 years [16]). Biochemical markers of endotoxaemia
, inflammation, and immune activation were measured. Ten patients were stud
ied within 1 week of complete resolution of oedema. Five patients survived
longer than 6 months and were restudied again after remaining free of oedem
a for more than 3 months.
Findings. Mean endotoxin concentrations were higher in oedematous patients
with chronic heart failure than in stable patients with chronic heart failu
re (0.74 [SD 0.45] vs 0.37 EU/mL [0.23], p = 0.0009) and controls (0.46 EU/
mL [0.21], p = 0.02). Oedematous patients had the highest concentrations of
several cytokines. After short-term diuretic treatment, endotoxin concentr
ations decreased from 0.84 EU/mL [0.49] to 0.45 EU/mL [0.21], p < 0.05) but
cytokines remained raised. After freedom of oedema for more than 3 months
after oedema resolved, endotoxin concentrations remained unchanged from the
previous visit (0.49 EU/mL [0.06], p = 0.45).
Interpretation. Raised concentrations of endotoxin and cytokines are found
in patients with chronic heart failure during acute oedematous exacerbation
. Intensified diuretic treatment can normalise endotoxin concentrations. Ou
r preliminary findings suggest that endotoxin may trigger immune activation
in patients with chronic heart failure during oedematous episodes.